Composition
- Active ingredients
- EMTRICITABINE 200MG; RILPIVIRINE HYDROCHLORIDE EQ 25MG BASE; TENOFOVIR DISOPROXIL FUMARATE 300MG
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA202123.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Complera
- Active substance
- emtricitabine
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Gilead Sciences Inc
- Status
- Prescription
- FDA approval
- 10 Aug 2011
- Application
- NDA202123-001